发明名称 Medicament comprising steviol or isosteviol for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
摘要 <p>A substance including the chemical structures of bicyclo[3.2.1]octan or the chemical structures of kaurene for the use in a dietary supplementation or as a constituent in a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome. The unique chemical structures of bicyclo[3.2.1]octan alone or in a kaurene structure provides the substances, such as e.g. steviol, isosteviol and stevioside with the capability of enhancing or potentiating the secretion of insulin in a plasma glucose dependent manner. The substances including these unique chemical structures also have the capability of reducing the glucagon concentration in the blood and/or lowering the blood pressure thereby providing a self-regulatory treatment system for non-insulin dependent diabetes mellitus and/or hypertension. In a combination drug which also comprise a soy protein, and/or soy fiber and/or at least one isoflavone these substances act synergistically and such combination drugs are highly useful both prophylacticly or directly in the treatment of e.g. the metabolic syndrome and obesity and has due to the self-regulatory effect a widespread applicability as a dietary supplementation.</p>
申请公布号 EP2330092(A2) 申请公布日期 2011.06.08
申请号 EP20100157966 申请日期 2001.02.01
申请人 STEVIA APS 发明人 HERMANSEN, KJELD;GREGERSEN, SOEREN;BENDIX-JEPPESEN, PER
分类号 A61K38/00;C07C13/64;A61K31/015;A61K31/045;A61K31/19;A61K31/352;A61K31/7034;A61K31/704;A61K36/00;A61K36/28;A61K36/48;A61K45/06;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P9/12;C07C13/68;C07C61/29;C07C61/35;C07C62/32;C07H15/24;C07H15/256 主分类号 A61K38/00
代理机构 代理人
主权项
地址